Delivery Order SPE2DB22D1106-SPE2DB25FETY8
- Not listed
- The Defense Logistics Agency awarded a $11,485.09 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. This non-set-aside award was competitively procured and is scheduled for completion by September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units, with a ceiling value of $8,195.85. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,214.32 to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 12, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,998.57 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewable units, with a completion date of September 29, 2025. This non-set-aside award was issued on September 26, 2025, with performance to be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected as...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewables valued at $10,005.69 with an ultimate completion date of April 28, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency awarded a $2,984.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,492.00 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables under contract 4568864711. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FETY8Delivery Order
The Defense Logistics Agency awarded a $22,395.03 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. The contract, which is classified as a child award under a larger indefinite delivery vehicle, requires performance completion by June 20, 2025, with fulfillment at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements in open competition. This award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain. The company holds a substantial $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2026, which serves as the umbrella vehicle enabling delivery orders for pharmaceutical products and medical supplies supporting military healthcare systems globally. AmerisourceBergen's federal contract portfolio encompasses a comprehensive range of medications and medical commodities across multiple therapeutic domains, positioning the company as a key supplier for Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 6/18/25 |